Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,343
Closed -$885K 497
2026
Q1
$885K Buy
2,343
+509
+28% +$218K 0.09% 349
2025
Q4
$785K Sell
1,834
-4,113
-69% -$1.79M 0.11% 367
2025
Q3
$2.66M Buy
5,947
+3,055
+106% +$1.38M 0.41% 54
2025
Q2
$1.41M Buy
+2,892
New +$1.65M 0.21% 187
2024
Q3
Sell
-931
Closed -$505K 422
2024
Q2
$505K Buy
+931
New +$533K 0.37% 106
2023
Q2
Sell
-1,348
Closed -$725K 376
2023
Q1
$725K Buy
1,348
+896
+198% +$457K 0.43% 53
2022
Q4
$231K Sell
452
-226
-33% -$110K 0.5% 117
2022
Q3
$296K Buy
678
+229
+51% +$110K 1.07% 25
2022
Q2
$211K Buy
+449
New +$219K 0.41% 151
2022
Q1
Sell
-555
Closed -$294K 397
2021
Q4
$294K Buy
+555
New +$266K 0.23% 208

Other funds holding CHE

Oak Thistle LLC's CHE Position: Q2 2026 in Review

Oak Thistle LLC sold out of Chemed (CHE) in Q2 2026, closing a stake of 2,343 shares — an estimated $885K sold.

Oak Thistle LLC first reported a position in CHE in Q4 2021 and held it in 10 quarters. The position peaked at $2.66M in Q3 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Oak Thistle LLC reported no remaining Chemed position as of Q2 2026 after selling out during the quarter.
  • Oak Thistle LLC sold 2,343 Chemed shares in Q2 2026, an estimated $885K.
  • Oak Thistle LLC first reported a position in Chemed in Q4 2021 and held it in 10 quarters.
  • Oak Thistle LLC's Chemed position peaked at $2.66M in Q3 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Oak Thistle LLC's 13F filing for Q2 2026, filed 21 Jul 2026.